Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
NCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 04221542 Brief Summary Evaluate the safety and tolerability of AMG…
Read more arrow_forwardNCT 05910827 Brief Summary This is a phase 1b multi-center, open-label…
Read more arrow_forwardNCT 05919537 Brief Summary This is a phase 1b multi-center, open-label study…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 06267729 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 04644068 Brief Summary This research is designed to determine if experimental…
Read more arrow_forwardNCT 05367440 Brief Summary This study will evaluate the safety, tolerability, pharmacokinetics…
Read more arrow_forwardNCT 06179511 Brief Summary This is a modular, multicentre, open-label, Phase…
Read more arrow_forwardNCT 04091126 Brief Summary This study will evaluate the safety, pharmacokinetics,…
Read more arrow_forward